A novel mechanism for TNF-alpha regulation by p38 MAPK: involvement of NF-kappa B with implications for therapy in rheumatoid arthritis.

作者: Jamie Campbell , Cathleen J. Ciesielski , Abigail E. Hunt , Nicole J. Horwood , Jonathan T. Beech

DOI: 10.4049/JIMMUNOL.173.11.6928

关键词:

摘要: TNF-alpha is a key factor in variety of inflammatory diseases. This study examines the role p38 MAPK regulation primary human cells relevant to inflammation, e.g., macrophages and rheumatoid synovial cells. Using dominant negative variant (D168A) kinase inhibitor, SB203580, we confirm that regulates production using posttranscriptional mechanism requiring 3' untranslated region gene. However, LPS-activated also detect second previously unidentified mechanism, modulation transcription. mediated through NF-kappaB. Interestingly this was not observed Importantly however, mutant MAPK, but SB203580 effective at inhibiting spontaneous these ex vivo cell cultures. These data indicate there are potential major differences signaling have bearing on use as target for therapy. results despite disappointing with inhibitors clinic, valid disease.

参考文章(46)
Fionula M Brennan, A follow-up to "Anti-cytokine therapy in chronic destructive arthritis" by Wim B van den Berg. Arthritis Research & Therapy. ,vol. 3, pp. 211- ,(2001) , 10.1186/AR302
Yanhua Bi, Clifford J. Bellone, Joseph J. Baldassare, The role of p38 mitogen-activated protein kinase in IL-1 beta transcription. Journal of Immunology. ,vol. 162, pp. 5367- 5373 ,(1999)
Agnes Denys, Irina A. Udalova, Clive Smith, Lynn M. Williams, Cathleen J. Ciesielski, Jamie Campbell, Caroline Andrews, Dominic Kwaitkowski, Brian M. J. Foxwell, Evidence for a dual mechanism for IL-10 suppression of TNF-alpha production that does not involve inhibition of p38 mitogen-activated protein kinase or NF-kappa B in primary human macrophages. Journal of Immunology. ,vol. 168, pp. 4837- 4845 ,(2002) , 10.4049/JIMMUNOL.168.10.4837
B Foxwell, E Andreakos, F Brennan, M Feldmann, C Smith, M Conron, Prospects for the development of small molecular weight compounds to replace anti-tumour necrosis factor biological agents. Annals of the Rheumatic Diseases. ,vol. 62, ,(2003) , 10.1136/ARD.62.SUPPL_2.II90
Jonathan L. E. Dean, Matthew Brook, Andrew R. Clark, Jeremy Saklatvala, p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. Journal of Biological Chemistry. ,vol. 274, pp. 264- 269 ,(1999) , 10.1074/JBC.274.1.264
Linda Vermeulen, Gert De Wilde, Petra Van Damme, Wim Vanden Berghe, Guy Haegeman, Transcriptional activation of the NF‐κB p65 subunit by mitogen‐ and stress‐activated protein kinase‐1 (MSK1) The EMBO Journal. ,vol. 22, pp. 1313- 1324 ,(2003) , 10.1093/EMBOJ/CDG139
Kuang-Den Chen, Liuh-Yow Chen, Huei-Luen Huang, Chien-Hui Lieu, Yen-Ni Chang, Margaret Dah-Tysr Chang, Yiu-Kay Lai, Involvement of p38 mitogen-activated protein kinase signaling pathway in the rapid induction of the 78-kDa glucose-regulated protein in 9L rat brain tumor cells. Journal of Biological Chemistry. ,vol. 273, pp. 749- 755 ,(1998) , 10.1074/JBC.273.2.749